Clinical Trial Update: Safety of Effivia®, a Bevacizumab Biosimilar

View source ↗

Summary

Completed safety data for Effivia, a bevacizumab biosimilar, from a clinical trial sponsored by Laboratorios Liomont. The study evaluated its safety in metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Effivia (bevacizumab biosimilar)

Snippet

Sponsor: Laboratorios Liomont | Conditions: Metastatic Colorectal Cancer, Metastatic Cervical Cancer | Status: COMPLETED